RAS oncogenes play a critical role in oncogenic transformation and metastases formation. Here we show that Ha-ras greatly stimulates spontaneous metastatic activity of transformed cells through the Ras/RalGDS/ RalA intracellular signaling pathway. Introduction of RalA alone leads to a drastic increase of metastatic activity of transformed cells. We demonstrate that metastatic ability of cells could be dramatically enhanced by RalA stimulation or, conversely, hampered by RalA suppression. Furthermore, we found that during in vivo selection cells acquire high metastatic properties as a result of endogenous RalA activation. The ability of RalA to induce metastasis was demonstrated in spontaneously transformed as well as in virus transformed fibroblasts.
Introduction
Metastasis -the spread of cells from the primary tumor to distant organs and their persistent growth -is the most fearful aspect of cancer. The process of cancer metastasis consists of a series of sequential, interconnected steps. The outcome of the process depends on both the intrinsic properties of the tumor cells and the responses of the host (Fidler, 2003) . The metastatic behavior of cancer cells could be determined relatively early in tumorigenesis, that is, a subset of the oncogenic factors acquired by tumor cells early in tumorigenesis confers also the proclivity to metastasize (Bernards and Weinberg, 2002) .
The grade of metastatic 'aggressiveness' is a constant characteristic for each transformed cell line and could be determined in vivo by two experimental trials. The first, experimental metastatic activity test (EMA) reflects the ability of tumor cells to survive in the bloodstream and to occupy other tissues. For this, analysed cells are introduced intravenously in experimental animals and the quantity of distant metastases (usually within the lungs) is calculated. For the second trial, spontaneous metastatic activity test (SMA), cells are inoculated subcutaneously and have to pass through all the stages of the metastatic process: primary tumor production, penetration into blood vessel and generation of distant metastases. The precise molecular events leading to the acquisition of the metastatic phenotype remain largely unclear. One of the possible approaches to clarify the mechanisms of metastasis might be the artificial modulation of the metastatic potential of cells by introduction of different exogenous agents.
Members of the Ras superfamily of small GTPbinding proteins have been implicated in the regulation of diverse biological functions, including tumor progression. Activating mutations in Ras genes are commonly found in a variety of human tumors (Bos, 1989; Chambers et al., 2002; Malumbres and Barbacid, 2003) . In addition, Ras oncogenic mutants stimulate both tumorigenic and metastatic properties of the rodent cells in culture (Chambers and Tuck, 1993) . In its active GTP-bound state, Ras triggers a number of signaling pathways through its capability to activate key effector proteins. A large body of evidence suggests a central role for the Raf-MEK-ERK1/2 pathway in a variety of Ras-mediated responses (Sprang, 1997) . More recent studies have implicated Raf-independent pathways in diverse biological events mediated by the Ras oncogene, including cytoskeletal reorganization, gene expression, and cell cycle progression (Urano et al., 1996; Rodriguez-Viciana et al., 1997; Downward, 1998; Moskalenko et al., 2002) . However, the defined Rasmediated signaling pathways and downstream genetic events responsible for acquisition of the metastatic phenotype remain to be elucidated.
A unique collection of transformed Syrian hamster embryo fibroblasts (HEF) was described previously (Deichman et al., 1989a (Deichman et al., , b, 1992 . Some of the cells (STHE cell line) were obtained as a result of spontaneous transformation in vitro. Others, such as HET-SR line, were transformed in vitro by the Schmidt-Ruppin strain of Rous sarcoma virus (RSV). All these cell lines were highly tumorigenic in vivo, but displayed different degrees of metastatic potential -that is, they differed significantly in SMA and EMA. RSV-transformed lines were seen to contain intact integrated provirus and to express abundant levels of v-Src mRNA, protein, and tyrosine kinase activity (Topol et al., 1993; Deichman et al., 1996) . By the yeast two-hybrid method, several proteins were identified that were not previously known to be v-src protein partners. However, the spectrums of cellular proteins that interact with v-src in the high or low metastatic cell lines do not differ significantly (Mizenina et al., 2001) . Comparative analysis of proteins, participating in different signal transduction pathways, demonstrate that variations in the focal adhesion complex, in Shc/Grb2 adaptor protein interaction and in MAP kinase cascade pathway, have no direct association with the metastatic phenotype of transformed cells. In the tested panel of cell lines, only the phosphorylation of PLC-g was specific for high metastatic cells independently of their origin (Nesterova-Galvin et al., 2004, submitted) .
In order to modulate the biological properties of transformed cells, an activated Ha-ras oncogene was subsequently introduced into selected cell lines. We found that Ha-ras stimulates the metastasis through Ras/RalGDS/Ral signaling pathway and that RalA protein itself is capable of stimulating the metastatic activity of spontaneously transformed and virus transformed fibroblasts by two orders of magnitude. We also show here that tumor cells with activated endogenous RalA gene are preferably selected in vivo and acquire high metastatic capacity. A constitutively active Ha-ras oncogene (V12Ha-ras mutant) (Rodriguez-Viciana et al., 1997) was transduced into the low metastatic HET-SR cell line and selected HET-SRV12 cells were analysed. It is noteworthy that unlike the standard procedure of similar researches, in which EMA test on athymic mice was applied (Webb et al., 1998; Ward et al., 2001) , in the present study, cells were examined on the experimental animals with native immune status using the SMA test. We observed enhancement of metastatic activity of HET-SRV12 cells to a very high extent: Dmet (average amount of the lung metastases per animal) increased from 2 (in parental line) to 110 ( Figure 2A , B).
Results

Ha
A region of the Ras protein known as the effector domain (amino acids 32-40 in Ha-Ras) has been shown to be essential for the interaction between Ras and a variety of effectors. Point mutations within the effector domain of oncogenic Ha-Ras (V12Ha-Ras) generate mutants deficient in specific effector function.
To determine the contribution of different Ras-associated signaling pathways to the high SMA of HET-SRV12 cells, we introduced into the HET-SR cells three Ha-rasV12 effector domain mutants: Figure 1 Origin of cell lines
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V12S35Ha-ras, V12G37Ha-ras, and V12C40Ha-ras (Rodriguez-Viciana et al., 1997), each of which can associate with only one effector (Joneson et al., 1996; White et al., 1996) (Figure 1 ). We compared the SMA of cells carrying corresponding Ras mutant containing vectors and revealed remarkable differences. Neither V12S35 mutant variant (which acts through the Ras/ Raf/MEK/ERK1/2 pathway) nor V12C40 mutant (which stimulates the Ras/PI3K/PKB signaling pathway), introduced into the HET-SR cells, caused any modulations in cells' metastatic behavior (Figure 2A, B) . At the same time, HET-SRG37 Ha-ras cell line with stimulated Ras/RalGDS/RalA pathway showed a drastic increase of SMA: (Dmet was 118), that is, the level of metastatic activity achieved approximately the level of HET-SR containing V12Ha-ras. All cells with exogenous Ha-ras mutants demonstrated an elevated amount of Ha-ras protein in comparison with the parental HET-SR line, including cells with unaltered low metastatic activity (HET-SRC40 and HET-SRS35 lines) (Figure 3a, b) .
RalA protein provides the SMA of RSV-transformed cells
In order to reveal the RalGDS downstream effectors responsible for Ha-RasG37 metastasis stimulation, we suppressed RalA (Chardin and Tavitian, 1986 ) activity in the highly metastatic HET-SRG37 line by the introduction of RalA/S28N dominant-negative mutant (Yamazaki et al., 2001 ). These cells, named HET-SRG37-Ral(À), demonstrated intense suppression of metastasis -SMA decreased to the level of parental HET-SR line (Figure 2a, b) . (Figure 2a, b) . Thus, RalA itself is able to stimulate the SMA of RSV-transformed cells by two orders of magnitude. In addition to this, we could demonstrate the reversible regulation of metastasis by stimulation and the suppression of RalA activity.
We compared the expression of active RalA protein in parental HET-SR cells, in highly metastatic Ha-ras mutants containing HET-SRV12 and HET-SRG37 cells, and in highly metastatic HET-SR-LNM cell line. The steady-state level of RalA protein production was approximately the same in all tested cultures (Figure 3c ). At the same time, we found noticeable elevation of the active form of RalA protein in Ha-rasV12 and HarasG37 carrying cells as well as in HET-SR-LNM cells (Figure 3d ). We surmised that the high level of metastasis of in vivo selected HET-SR-LNM cells was caused by activation of endogenous RalA.
The selection of highly metastatic RSV transformed cell variants in vivo is associated with enhanced endogenous RalA activity
To test the possible responsibility of endogenous RalA for high metastatic cell selection, the activity of this protein was neutralized by introducing RalA/S28N dominant-negative mutant into the HET-SR-LNM line (Figure 1 ). The analysis of the metastatic activity of the HET-SR-LNM-Ral(À) cells demonstrated total inhibition of both EMA and SMA. SMA decreased to the level of HET-SR line: Dmet reduced from 143 to 4.4 (Figure 2 ). The suppression of EMA was also very significant, that is, a decrease of more than one order of magnitude (Figure 4) . Thus, the suppression of endogenous RalA activity leads to the loss of highly metastatic phenotype.
To investigate whether the high EMA of parental HET-SR line also depends on endogenous RalA activity, these cells were infected with the lentivirus containing RalA/S28N dominant-negative mutant. The infected cells HET-SR-Ral(À) showed up a drastic decrease of EMA, confirming the hypothesis that the high EMA level of HET-SR cells directly depends on endogenous RalA activity (Figure 4) . Thus, the level of RalA activity in HET-SR cell line is sufficient to provide high EMA, but is not sufficient to cause high SMA. Therefore, we observed a correlation between the level of endogenous RalA activity (Figure 3c, d ) and the metastatic behavior of RSV-transformed cells.
RalA contributes to the metastatic power of spontaneously transformed cells
Next, we examined the capacity of RalA to induce the metastatic properties of spontaneously transformed cell line, which does not contain any exogenous transforming agent and demonstrates very low EMA and SMA. For this, an activated RalA gene was introduced into STHE cell line (Figure 1 ). EMA and SMA of STHERal( þ ) cells were tested. We observed a dramatic (Figure 4a, b) . The SMA of STHE-Ral( þ ) cells remained at the level of parental STHE cell line (data not shown).
The differences in tumorigenic activity between all cell lines described above were not statistically significant according to Kruskal-Wallis test (P>0.01). Thus, drastic changes in metastatic behavior are not correlated with the modulation of tumorigenicity of presented cell lines.
Discussion
In this study we demonstrate that activated Ha-ras stimulates the SMA of RSV-transformed hamster fibroblasts and that this stimulation is provided through Ras/RalGDS/RalA pathway, and namely by RalA. This finding was unexpected, because several previous experiments in mice cells identified Ras/Raf/Erk1/2 signaling pathway as the most important for oncogenesis and metastasis (Khosravi-Far et al., 1996; Rodriguez-Viciana et al., 1997; Webb et al., 1998; Pawlak and Helfman, 2002) . At the same time, it was shown that Ral-associated pathway increases the cell survival, proliferation rate and anchorage independence of cell growth (Urano et al., 1996; White et al., 1996; Miller et al., 1997; Yamazaki et al., 2001; Yu and Feig, 2002; Chien and White, 2003) . Using the EMA test on athymic mice, the role of RalGEF in dissemination of metastases was demonstrated (Ward et al., 2001) .
Our data indicate that:
(i) endogenous RalA activity of HET-SR line provides high EMA, but its level is not sufficient for providing high SMA; (ii) in vivo selection of HET-SR cells leads to the appearance of highly metastatic cell variants with enhanced endogenous RalA activity. This high SMA phenotype is also provided by RalA and might be reverted to the level of parental cells by the suppression of its activity; (iii) introduction of RalA greatly contributes to the metastatic capacity of both RSV-transformed cells and spontaneously transformed cells. It is interesting that in this last case, RalA protein enhances only EMA.
Thus, activation of the RalA associated pathways is sufficient to provide the transformed cells with the main features necessary for metastasis. These features probably include cell migration and invasiveness -it was shown recently that Ral seems critical for cell motility (Suzuki et al., 2000; Gildea et al., 2002) . However, to achieve complete metastatic potential, additional factors might be needed. Tumor suppressor genes and protooncogenes are possible candidates to be involved in this process. It was shown that several endogenous protooncogenes, including ras gene family and c-src, are expressed in these cell lines without any correlation between the levels of metastasis and protein activity (Topol et al., 1993; Deichman et al., 1996) .
At the same time, suppression of endogenous RalA activity leads to the total loss of both experimental and SMA. We suggest that RalA might be a critical factor involved in the process of metastasis development.
Recently, it was found that oncogenic Ras may transform murine and human cells by distinct mechanisms. Introduced RalGEF-specific Ha-RasV12G37 mutant gave rise to transformation of different human cells, while Raf-and PI3-kinase-specific Ha-RasV12S35 and Ha-RasV12C40 mutants were practically ineffective (Hamad et al., 2002) . Thus, the RalGEF pathwaywhich seemed previously to play a secondary role in Ras transformation -was found to be the most essential for Ras induced oncogenic potential in human cancers. It is possible that molecular events responsible for tumor progression in hamster and human cells are somewhat similar. We suggest that our findings on hamster cells provide a unique experimental system for the identification of genes and molecular events mediating metastasis and may open new potential targets for gene therapy.
Materials and methods
Cell cultures
Parental cell lines HET-SR -line of HEF transformed in vitro by Schmidt-Ruppin D strain of RSV highly tumorigenic in animals, disposed high level of EMA and low level of SMA; HET-SR-LNM -highly metastatic in vivo selected variant of HET-SR line isolated from lymph node metastasis; STHElow metastatic spontaneously transformed in vitro HEF (Deichman et al., 1989a, b) . All cell lines (Figure 1 ) were maintained in 5% CO 2 in DMEM medium supplemented with 4 mM L-glutamine and 7% fetal bovine serum.
Plasmids and viral vectors
Variants of retroviral vector pLSXN, expressing Ha-Ras mutant variants Ha-rasV12, Ha-rasV12S35, Ha-rasV12C40, and Ha-rasV12G37, were provided by J Downward (Imperial Cancer Research Fund, UK) (Rodriguez-Viciana et al., 1997) . Plasmids carrying rat RalA mutants (RalA-G23V -constitutively activated mutant and RalA-S28N -dominant-negative mutant) were kindly provided by H Koide (Kanazawa University, Japan) (Yamazaki et al., 2001) . The sequences of RalA mutants were amplified by polymerase chain reaction with the following primers: RalA-G23V was subcloned into the retroviral vector pLXSN using XhoI-BamHI sites.
For expression of RalA-S28N dominant-negative mutant appropriate amplified fragment was ligated into the lentivirus vector pLV-CMV.
Recombinant viruses production and infection
All of retroviral constructs were transfected into Phoenix packaging cell line using LipofectAMINE PLUS Reagent (Life Technologies, GibcoBRL). Virus-containing supernatants were collected 24-48 h after transfection and used to infect recipient cells in the presence of Polybrene (8 mg/ml). Total pools of infected cells were selected in G418-containing medium (0.8 mg/ml).
High-titer stock of recombinant lentivirus pseudotyped with VSV-G protein was produced by cotransfection into 293T cells of pLV construct together with the pCMVdelta8.2 packaging plasmid and pVSV-G. Virus-containing supernatant was collected 24-48 h after transfection and used to infect recipient cells.
Animal housing
Adult (2 months old) healthy Syrian hamsters were put on EMA or SMA trials.
All manipulation with experimental animals was executed according to the sanitary and ethical rules on the equipment and maintenance of experimental biological clinics stated by the Main State Health Officer of Russian Federation (order N 1045-73 from 6 April 1973).
Metastasis assay
Experimental metastasis activity test (EMA) EMA was determined by intravenous inoculation of 10 normal adult hamsters with 10 5 cells per animal in the case of STHE cell line or 10 4 cells in the case of HET-SR, HET-SR-2SC and their derivatives. Single-cell suspensions were inoculated in a volume of 1 ml/animal into the retro-orbital venous sinus. Experimental animals were killed 24 days later and the amount of experimental lung metastases was counted using a dissection microscope. EMA test for each cell line was executed twice.
Spontaneous metastasis activity test (SMA) SMA was determined by subcutaneous inoculation of 10 normal adult hamsters with 2 Â 10 4 cell dose of each cell variant (0.2 ml of cell suspension per animal). Experimental animals were killed 8 weeks later and the amount of experimental lung metastases was counted using a dissection microscope. SMA test for each cell line was executed twice.
Western blot analysis
Cells were washed with ice-cold PBS, lysed on ice in a standard Ripa buffer containing protease inhibitor cocktail (Roche Diagnostics GmbH), 1 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF. Clarified total protein extracts (60 mg ) were separated by 15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto nitrocellulose membrane (BA 83, Schleicher & Schuell) in 25 mM Tris/0.2 M glycin/20% ethanol transfer buffer. Total proteins were visualized by Ponceau S staining as a loading control. Membrane was blocked in PBS/ 0.1% Tween-20/5% non-fat dry milk containing buffer and probed with anti-Ha-ras primary antibodies (F235, sc-29; Santa Cruz Biotech Inc.) and secondary anti-mouse HRPconjugated IgG (sc-2031; Santa Cruz Biotech Inc.). Immunoreactivity was detected by ECL kit (Amersham Pharmacia Biotech).
RalA activation assay
Active form of RalA protein was studied by Ral Activation Assay Kit (#17-300; Upstate Biotech), following the manufacturer's instructions. For the detection of an active RalA, cultured cells at 80% confluence were rinsed twice with icecold PBS and lysed in Ral Activation Assay buffer (#20-196; Upstate Biotech). Cell lysates were precleared by adding of glutation agarose (100 ml per 1 ml of lysate) and rocking 10 min under 41C. Extracts were immunoprecipitated with RalBP1-agarose (#14-415; Upstate Biotech). The beads were loaded on a 15% SDS-PAGE, transferred to a membrane and immunoblotted with anti-RalA antibodies (#05-586; Upstate Biotech). A sample of total lysate of each tested cell culture was separated in the same gel for immunoblotting with anti-RalA antibodies as a control.
Quantitative evaluation of data
Scanned blots were analysed by Gel-Pro Analyzer version 3.1. (Media Cybernetics) using 1D-Gels regime.
